Piezoelectric materials — validated parameters

Source agent: h02 parameter provenance audit (Sonnet 4.6), 2026-04-23. Consumer: piezo_voltage_budget.py, piezo_phase2_frequency_bundle.py.

Parameter table

ParameterValueSourceConditionsStatusNotes
PVDF-TrFE (70/30) d31−8 to −12 pC/NManufacturer specs (Arkema Piezotech, APC Int’l)β-phase, poled film⚠ manufacturerConservative range; well-poled film may reach −25 pC/N
PVDF-TrFE (70/30) d33>20 pC/NArkema Piezotech; Frontiers Energy 2021 in-situ polingβ-phase⚠ manufacturerd31 and d33 are related but different modes
PVDF-TrFE (70/30) eps_r8.0–9.0Arkema Piezotech datasheet; piezopvdf.com1 kHz, 25°C⚠ manufacturerScript uses 10.0 — slightly high
PVDF-TrFE (70/30) E_mod>3 GPaArkema Piezotech datasheetbulk film⚠ manufacturerResearch range 1.5–4 GPa for thin films
P(VDF-TrFE-CFE) terpolymer d33~40 pm/V (≈40 pC/N)Arkema Piezotech; relaxor ferroelectric literaturelow-field, unpoled⚠ manufacturerd31 somewhat lower; exact value composition-dependent
P(VDF-TrFE-CFE) eps_r>50Arkema Piezotech; piezopvdf.com CFE07 product1 kHz, 25°C⚠ manufacturerConsistent with script value of 50
P(VDF-TrFE-CFE) E_mod~1.2 GPaestimate (softer than copolymer)No primary paper found; plausible direction
PLLA d14 (shear mode)~10 pC/NPLLA is shear (d14), not transverse (d31). Scripts treat d14 as equivalent to d31 — this is a model approximation requiring flagging.
BaTiO3 d31−78 pC/Ntextbook / standardbulk ceramicReference only; Ba²⁺ toxicity precludes cochlear use
No-poling PVDF-TrFE (PEDOT:PSS templated)enhanced β-phase, d33 not yet quantified2026-04-21-wu-pvdf-trfe-pedotpss-piezoelectric (Wu et al. ACS AEM 2026, PMID 42004736)PEDOT:PSS + paper substrate✅ paper note existsKey fabrication advance: eliminates high-voltage poling step

Phase 1 vs Phase 2 d31 inconsistency

CRITICAL FLAG: piezo_voltage_budget.py uses d31 = −12 pC/N for PVDF-TrFE; piezo_phase2_frequency_bundle.py uses d31 = −25 pC/N for the identical material. This 2× discrepancy propagates into all voltage outputs. The Phase 2 value (−25 pC/N) is achievable for well-poled film; the Phase 1 value (−12 pC/N) is conservative β-phase. Neither is cited. Scripts must be reconciled to a single canonical value with a primary literature source.

Recommended canonical value: d31 = −12 pC/N (conservative, β-phase, consistent with manufacturer range 8–12 pC/N) until a primary paper is cited for the higher value.

OHC membrane constants (from same scripts, electroacoustic interface)

ParameterValueSourceStatusNotes
OHC specific membrane capacitance0.9 µF/cm² (9e-3 F/m²)Gentet et al. 2000, Biophys J 79:314–320⚠ NEEDS PDFScripts cite “Ashmore 1987” but 0.9 µF/cm² is Gentet 2000. Ashmore 1987 (J Physiol 388:323) established electromotility; specific capacitance was quantified later.
OHC specific membrane resistance~kΩ·cm² (1e-3 Ω·m²)generic excitable membrane❌ NEEDS LITERATURENo primary OHC-specific citation in scripts.
Prestin operating voltage threshold10 mV (model gate)Santos-Sacchi 1991, J Neurosci 11:3096 (PMID 1941076)⚠ NEEDS PDFPaper exists and is the correct reference for NLC voltage sensitivity. “10 mV threshold” is a model simplification — prestin NLC operates over −150 to +50 mV; 10 mV is the signal modulation amplitude assumed sufficient for amplification.
Prestin V_saturation70 mVno citation❌ NEEDS LITERATUREUnsourced.

Papers to retrieve for this topic

PaperWhat it provides
Ashmore JF (1987) J Physiol 388:323–347OHC electromotility origin; correct citation for C_spec claim
Gentet LJ et al. (2000) Biophys J 79:314–320Specific membrane capacitance 0.9 µF/cm²
Santos-Sacchi J (1991) J Neurosci 11:3096 (PMID 1941076)Prestin NLC voltage dependence
Arkema Piezotech PVDF-TrFE datasheetd31, eps_r, E_mod — manufacturer values for modelling
Wu et al. (2026) ACS AEM PMID 42004736No-poling β-phase PVDF-TrFE via PEDOT:PSS — paper note already exists

Connections